| scholarly article | Q13442814 |
| P2093 | author name string | Qi Zhang | |
| Bingwei Shi | |||
| Zhixiang Ding | |||
| Xiaojing Tian | |||
| Wentao Jin | |||
| Gaochao Qian | |||
| P2860 | cites work | Galactosylceramide affects tumorigenic and metastatic properties of breast cancer cells as an anti-apoptotic molecule | Q27335599 |
| Adoptive immunotherapy for cancer: harnessing the T cell response | Q28262548 | ||
| Generalized lymphoproliferative disease in mice, caused by a point mutation in the Fas ligand | Q28513283 | ||
| Cytoprotective effect of glucosylceramide synthase inhibition against daunorubicin-induced apoptosis in human leukemic cell lines | Q34295244 | ||
| Activation-induced cell death: the controversial role of Fas and Fas ligand in immune privilege and tumour counterattack | Q34592338 | ||
| Activation-induced cell death in T cells | Q35129715 | ||
| Activation of tumor antigen-specific cytotoxic T lymphocytes (CTLs) by human dendritic cells infected with an attenuated influenza A virus expressing a CTL epitope derived from the HER-2/neu proto-oncogene | Q35149885 | ||
| Immune responses to Yersinia enterocolitica in susceptible BALB/c and resistant C57BL/6 mice: an essential role for gamma interferon | Q35783031 | ||
| Simplified method of the growth of human tumor infiltrating lymphocytes in gas-permeable flasks to numbers needed for patient treatment | Q35860034 | ||
| Induction and molecular signature of pathogenic TH17 cells | Q36283752 | ||
| Activation of natural killer T cells by alpha-galactosylceramide rapidly induces the full maturation of dendritic cells in vivo and thereby acts as an adjuvant for combined CD4 and CD8 T cell immunity to a coadministered protein | Q36371349 | ||
| Adoptive regulatory T-cell therapy protects against cerebral ischemia | Q37107049 | ||
| Adoptive regulatory T-cell therapy preserves systemic immune homeostasis after cerebral ischemia | Q37492747 | ||
| Tumor-specific cytotoxic T cells are crucial for efficacy of immunomodulatory antibodies in patients with lung cancer | Q38098498 | ||
| Dendritic cell internalization of α-galactosylceramide from CD8 T cells induces potent antitumor CD8 T-cell responses | Q39452603 | ||
| NKT cells enhance CD4+ and CD8+ T cell responses to soluble antigen in vivo through direct interaction with dendritic cells | Q40618321 | ||
| Fas/Fas ligand interactions promote activation-induced cell death of NK T lymphocytes | Q42635754 | ||
| Fas(CD95)/FasL interactions required for programmed cell death after T-cell activation. | Q42830166 | ||
| High doses of alpha-galactosylceramide potentiate experimental autoimmune encephalomyelitis by directly enhancing Th17 response. | Q51887691 | ||
| Experimental autoimmune encephalomyelitis induction in naive mice by dendritic cells presenting a self-peptide | Q77703439 | ||
| Specificity, magnitude, and kinetics of MOG-specific CD8+ T cell responses during experimental autoimmune encephalomyelitis | Q81129297 | ||
| P433 | issue | 5 | |
| P304 | page(s) | 5026-5034 | |
| P577 | publication date | 2015-05-01 | |
| P1433 | published in | International Journal of Clinical and Experimental Pathology | Q6051341 |
| P1476 | title | Cytoprotective effects of high dose of α-galactosylceramide against activation-induced CD4+ T and CD8+ T cell death as an adjuvant | |
| P478 | volume | 8 |
Search more.